Endothelin association with cultured rat hepatic endothelial cells: functional characterization  by Eakes, Ann T et al.
 .Biochimica et Biophysica Acta 1359 1997 153–164
Endothelin association with cultured rat hepatic endothelial cells:
functional characterization
Ann T. Eakes, Stephen A.K. Harvey, Merle S. Olson )
Department of Biochemistry, The Uni˝ersity of Texas Health Science Center at San Antonio, 7703 Floyd Curl Dri˝e, San Antonio, TX
78284-7760, USA
Received 27 May 1997; accepted 29 May 1997
Abstract
Endothelin is a potent vasoactive peptide whose concentration increases in a number of pathophysiological states. In the
w125 x w125 x .intact animal, the liver is known to sequester f12% of an injected bolus of I endothelin-1 I ET-1 . Endothelial
 .cells ECs isolated from rat liver were maintained in culture in order to examine their role in ET sequestration. LECs were
shown to express predominantly ET receptors both by association assays and by Northern blot analysis. In these cells theB
w125 xreaction between I ET-1 and its receptor was essentially irreversible. Ligand binding experiments performed at 48C
 . 6showed that LECs in early culture f3 h had 4.3"0.8 fmol of ET receptors per 10 cells; this number fell progressively
to F1 fmolr106 cells during 24 h of culture. The decrease in receptor numbers could be blocked by maintaining the cells
at 48C. Northern blot analysis showed that relative to freshly isolated cells, mRNA for the ET receptor decreased 4-fold inB
w125 xearly culture, and recovered somewhat at 24 h. At 378C I ET-1 bound by the cells was rapidly internalized, with
concomitant down-regulation of ET receptors. Recovery of down-regulated ET receptors was sensitive to cycloheximide,
w125 x  .making short-term receptor recycling unlikely. Metabolism of I ET-1 was low at short -4 h exposure times, and at 24
h showed a concentration dependence similar to that of ligand association, suggesting that ET-1 metabolism primarily was
intracellular. ET stimulation of Kupffer cells and other hepatic cell types is known to activate phosphoinositide signaling,
but no such activation was seen in LECs. Moreover, ET did not appear to stimulate protein tyrosine kinase activity in LECs.
While hepatic LECs may lack some of the ET-dependent responses seen in other cell types, they likely contribute
substantially to the liver’s previously reported ability to sequester systemically administered ET. q 1997 Elsevier Science
B.V.
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1. Introduction
The endothelins are potent vasoactive peptides des-
ignated ET-1, -2, and -3 which are released from a
variety of cells, including vascular endothelial cells
w x1 . Tissue expression of ET coincides with the local-
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ization of its receptors, suggesting that ET acts as a
local hormone effective in paracrine or autocrine
w xactions within the tissue where it is produced 2 .
Many bioactive substances, such as endotoxin, argi-
nine vasopressin and transforming growth factor-b,
and numerous pathophysiological conditions, includ-
ing sepsis, hypoxia and cirrhosis, stimulate cells to
w xproduce and release ET 3–5 . Elevated levels of
circulating ET are associated with several types of
hepatic dysfunction e.g. cirrhosis, endotoxemia and
w x.liver transplantation; for reviews see 6,7 . More-
over, ET receptor abundance may be elevated in
some tissues in response to ischemiarreperfusion or
w xdrugs such as the immunosuppressant cyclosporin 8 .
Upon binding of ET to its receptor, several signaling
pathways are activated. These pathways include
phospholipase C activation of the inositol phosphate
cascade, phospholipase A -mediated increases in2
eicosanoid synthesis and the mitogen activated pro-
 . w xtein kinase MAP kinase cascade 9 .
The ET receptor is a single chain protein with
seven transmembrane segments, typical of a G pro-
w xtein-coupled receptor 10,11 . In mammals, two dis-
tinct forms of the receptor have been found and are
designated ET and ET . Endothelin receptor sub-A B
types are distinguished on the basis of their binding
affinity for ET-1 and ET-3. The ET receptor has aA
higher affinity for ET-1 than for ET-3, while the ETB
receptor exhibits an equal affinity for both ET-1 and
w xET-3 12 . The ET receptor has been identified inC
Xenopus dermal melanocytes and was shown to pre-
w xfer ET-3 over ET-1 13 .
Recent reports have described experiments using
cultured endothelial cells which have highlighted the
significance of ET as an autocoid effector. In some
cell preparations, the secretion of ET peptide is high
enough to attenuate or abrogate the association of
w125 xI ET-1. Phosphoramidon is an inhibitor of the ET
 .converting enzyme ECE , and inhibits secretion of
ET. It is known that phosphoramidon inhibition of
w125 xECE can cause an increase in I ET-1 association
and ET-mediated signal transduction in endothelial
cells, suggesting that secreted ET is responsible for
w xautocrine down-regulation of ET receptors 14 . In
w125 xone report, specific binding of I ET-1 to human
 .umbilical vein endothelial cells HUVECs was not
detectable unless phosphoramidon was present to in-
w xhibit endogenous production of ET 15 . Cultured
w x w xLECs isolated from guinea pig 16 or rat 17 are
capable of synthesizing and releasing immunoreac-
 .tive ET irET , and treatment with TGF-b augments
the release of peptide several fold. However, the
basal level of irET secretion by rat LECs is substan-
tially lower than that reported in the literature for
endothelial cells from other tissues. We hypothesized
that under these conditions, the association of
w125 xI ET-1 with LECs should be measurable without
the addition of the inhibitor phosphoramidon. In the
present study we have characterized the ET receptor
type in LECs by Northern analysis, and have com-
pared this data with a functional assessment of the
cell receptor i.e. detectable cellular association of
w125 x .I ET-1 .
Endothelial cells play a substantial role in the
sequestration andror metabolism of circulating ET.
In cultured HUVECs, ET receptors are thought toB
w xbe responsible for the uptake of vascular ET 18 . We
w x have shown previously 19 that Kupffer cells resi-
.dent hepatic macrophages are capable of metaboliz-
w125 xing I ET-1. The concentration-dependence of this
metabolism is similar to the concentration depen-
w125 xdence of I ET-1 association, suggesting that lig-
and–receptor binding was necessary for its
metabolism. The kinetics of metabolite appearance
suggested that internalization of the ligand–receptor
w125 xcomplex precedes I ET-1 breakdown. In the pre-
sent study we show that a similar relationship exists
between ET uptake and metabolism in LECs, under-
lining the importance of the cellular complement of
ET receptors in controlling the level of circulating
ET, and providing an explanation for a major role for
w xthe liver in sequestering ET in the whole animal 20 .
2. Materials and methods
2.1. Animals
 .Male Sprague-Dawley rats SASCO, Omaha, NE
weighing between 175 and 225 g were fed a standard
rat chow and water ad libitum. Animals were handled
in compliance with the Animal Welfare Act and
according to the guidelines set forth by the United
States Department of Agriculture. All protocols were
approved by the Institutional Animal Care and Use
Committee of The University of Texas Health Sci-
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ence Center at San Antonio which is accredited by
the American Association for the Accreditation of
Laboratory Animal Care.
2.2. Reagents
Collagenase Type IV from Clostridium his-
. tolyticum , protease E Type XIV from Streptomyces
. griseus and bovine serum albumin fraction V and
.essentially fatty acid free were purchased from Sigma
 .St. Louis, MO . RPMI-1640 tissue culture media
 .was purchased from Gibco Grand Island, NY .
Iron-supplemented calf serum was purchased from
 . w Hyclone Logan, UT . Metrizamide 2- 3-acetamido-
.5-N-methylacetamido-2,4,6-triiodobenzamido -2-
xdeoxy-D-glucose was purchased from Nyegaard and
 .Co. Oslo, Norway . ET-1, ET-3, and BQ-123 were
purchased from Peninsula Laboratories Inc. Be-
. w125 x  .lmont, CA . I ET-1 2000 Cirmmol was pur-
chased from DuPont-New England Nuclear Boston,
.MA . All other reagents used were purchased from
Sigma or a comparable supplier and were of the
highest quality available.
2.3. Isolation and primary culture of sinusoidal en-
dothelial cells
Rat sinusoidal endothelial cells were isolated as
w xpreviously described by Knook and Sleyster 21 .
Cells were suspended in RPMI-1640 medium supple-
mented with 20% iron-supplemented calf serum,
0.01% heparin, 2 mM L-glutamine, and 5000 Urml
penicillin and 5000 mgrml streptomycin. Aliquots of
 6 .cell suspension 2=10 cellsrml were plated at 4
mr60-mm dish, 2 mlr35-mm well or 0.5 mlr16-mm
well, on dishes previously coated with rat tail colla-
 .gen UBI, Lake Placid, NY , and placed in an incuba-
tor at 378C in an atmosphere of 95%r5% airrCO .2
After allowing up to 4 h for attachment, the cells
were placed in serum-free medium containing 0.1%
BSA and other additions were made as indicated in
 .the figure legends. Plating efficiency 75–80% was
determined by counting the adherent cells using a
phase contrast microscope after placing the cells in
serum-free medium, so that calculations are made for
3=106 cellsr35 mm well or 0.75=106 cellsr16
mm well. Unless otherwise noted, cells were cultured
overnight in serum-free medium prior to use. The
purity of the cultured cells was assessed by a peroxi-
dase staining reaction to distinguish the liver endothe-
lial cells from Kupffer cells. Functionality of the cells
was ascertained by the ability of the cells to take up
acetylated-LDL which was labeled with the fluores-
cent tag DiI.
2.4. Measurement of endothelin receptor mRNA
Total RNA from freshly isolated rat liver endothe-
lial cells or from endothelial cells cultured for speci-
fied periods of time was isolated using the method of
w xChomczynski and Sacchi 22 . The same method was
used to isolate total RNA from Polytron-generated
 .homogenates 0.5 g tissuer3 ml Trizol of rat liver or
rat lung. RNA was separated on 1% formal-
dehyderagarose gels and transferred to nylon mem-
branes. Northern blot analyses were performed on the
membranes using a cDNA to the rat ET receptorB
w xkindly provided by Dr. Shigetada Nakanishi 23 and
w xa cDNA to the rat ET receptor 10 , a generous giftA
of Dr. Harvey Lodish. The probes were labeled to a
high specific activity by random-primer labeling us-
w 32 xing a- P dCTP. Stringency washes were performed
sequentially as follows: at room temperature for 20
min in 2= SSC with 1% SDS, 30 min at 608C also
in 2= SSC with 1% SDS, 30 min at 608C in 1=
SSC with 0.5% SDS, and 30 min at 558C in 0.1=
SSC with 0.1% SDS. Differences in the amounts of
ET receptor mRNA were quantitated using a Molecu-
lar Dynamics PhosphorImager and variations in sam-
ple loading were adjusted relative to the level of
sample hybridization to an 18S RNA probe.
[125 ]2.5. I ET-1 association and metabolism assays
 .Hank’s buffered salt solution HBSS containing
0.1% BSA and 20 mM Hepes was used for all
radioligand association experiments. Endothelial cells
in primary culture were incubated in 1 ml per 35
.  .mm well or 0.25 ml per 16 mm well aliquots of
w125 xHBSS containing 5–10 pM of I ET-1 and various
concentrations of unlabeled ET-1 or ET-3. In all
binding and association experiments ET-1, ET-3 or
w125 xBQ-123 was first mixed with I ET-1, and the
mixture was then added to the cells. The association
was terminated by aspirating the medium from the
 .cells, and free radio ligand was removed by washing
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the cells 3 times with HBSS. The cells were solubi-
 .lized in 4% wrv sodium deoxycholate, and trans-
ferred to scintillation vials. Cell-associated radioactiv-
ity was quantitated using scintillation counting. Total
w125 xand nonspecific I ET-1 association were deter-
mined in the absence and presence of a 1000-fold
excess of unlabeled ET, respectively. Specific associ-
ation was determined by subtracting nonspecific as-
sociation from total association.
In experiments to distinguish surface and internal-
ized radioligand, assays were terminated by placing
the cells on ice, aspirating the medium and washing
three times with ice-cold buffer to remove unbound
radioligand. Surface bound radioligand was measured
by washing the cells four times for 20 min each with
ice-cold acidic medium 0.5 M NaCl, 0.2 M acetic
.acid, pH 2.5 and combining the acid washes. Inter-
nalized radioligand was measured by solubilizing the
acid-washed cells as described above.
w125 xIn experiments measuring I ET-1 metabolism,
the incubation medium was removed from the cells
and centrifuged for 10 min at 14 000=g at 48C.
Supernatants were removed and sufficient ice-cold
 .trichloroacetic acid TCA; 90–100% wrv was added
to them to give a final concentration of 10% wrv.
Acidified samples were again centrifuged, and the
 .supernatants containing TCA-soluble metabolite s of
w125 xI ET-1 were removed from precipitated
w125 xBSAr I ET-1. Radioactivity was measured both in
supernatants and precipitates.
3. Results
3.1. Characterization of the endothelin receptor in
( )li˝er endothelial cells LECs
Cells were cultured in the absence or presence of
20% iron-supplemented calf serum. Total RNA from
these cells was subjected to Northern blot analysis
 .Fig. 1 . Lung tissue is known to possess both ETA
w xand ET receptor subtypes 24 and provides a posi-B
tive control for both types of receptor mRNA. Fig. 1
shows that LECs are capable of synthesizing the ETB
 . nonselective receptor, but not the ET ET-1 selec-A
.tive receptor. Neither ET nor ET receptor mRNAA B
was detected in total RNA extracted from whole
liver, because approximately 60% of cells in the liver
w x w xare hepatocytes which we 25 and others 26 have
shown possess a relatively low capacity to bind ET.
Receptor function was measured as association of
w125 xI ET-1 with LECs using a 378C, 1 h protocol
 w x.Fig. 2; see 27 . Unlabeled ET-3 was as effective as
w125 xunlabeled ET-1 in competing with I ET-1 associa-
tion. Moreover, the ET receptor-selective antagonistA
BQ-123 was ineffective at competing with radioli-
gand association at concentrations as high as 1 mM.
These data confirm that the LEC endothelin receptor
 .is the ET nonselective isoform.B
3.2. ET binding at 48C
To measure cell surface binding LECs were ex-
w125 xposed to I ET-1 at 48C in order to attenuate
internalization of the ligand. In a number of different
cell types, the binding of ET to its receptor is essen-
w xtially irreversible 27–31 . In an initial experiment,
addition of a 1000-fold excess of unlabeled ET-1 was
unable to displace bound radioactivity, even after 40
 .h of incubation data not shown . This finding con-
w125 xfirmed that the association of I ET-1 with its
receptor was irreversible. Accordingly, surface recep-
tor numbers were estimated by titrating freshly adher-
ent cells with increasing concentrations of ET-1 at
 .48C for 24 h Fig. 3 . These experiments yielded a
6 value of 4.3"0.8 fmolr10 cells mean"S.D. for
.five independent experiments , or about 2600 recep-
torsrcell. However, when cells were cultured for 24
Fig. 1. LECs contain mRNA for the ET endothelin receptor.B
 .  .  .Total RNA 20 mg from whole liver Li , whole lung Lu and
LECs cultured for 4 h in the absence BSA; 0.1% bovine serum
.  .albumin in medium or presence of 20% calf serum CS was
separated on a 1% formaldehyderagarose gel, transferred to a
nylon membrane and sequentially probed for ET receptorB
mRNA, ET receptor mRNA and 18S RNA as described inA
Section 2. A: ET receptor; B: 18S.
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Fig. 2. Endothelin receptor expressed in LECs is ET . LECsB
were incubated for 1 h at 378C in the presence of 4–6 pM
w125 xI ET-1 and various concentrations of unlabeled ET-1, ET-3 or
BQ-123. Assays were terminated and cell-associated radioactivity
determined as described in Section 2. Data are mean"standard
 .deviations for duplicate determinations in each of six ET-1 , four
 .  .ET-3 and three BQ-123 experiments. Cell association with
w125 x I ET-1 alone was 3503"1310 d.p.m. mean"standard devia-
.tion; ns26 . Filled squares, ET-1; open squares, ET-3; open
triangles, BQ-123.
h at 378C prior to assay, the number of receptors fell
dramatically to -1 fmol of peptider106 cells. Main-
taining the cells at 48C for 24 h largely preserved
receptor numbers, presumably by attenuating basal
receptor internalization. Total RNA was extracted
 .  .from LECs which were i freshly isolated ii freshly
 .  .adherent i.e. after medium change at 2–4 h or iii
cultured for 24 h. The level of mRNA for ETB
receptors was much less in freshly adherent cells,
approximately 25%, of that seen in freshly isolated
 .LECs Fig. 4 . After 24 h in culture the level of ETB
receptor mRNA was still only 50% of the mRNA
level in freshly isolated cells, suggesting that recep-
tors are lost of because of the cells’ inability to
synthesize the receptor de novo.
3.3. ET binding and internalization at 378C
In order to examine the dynamics of ET-1 seques-
w125 x  .tration, association of I ET-1 with LECs Fig. 5
was measured at 378C. These data represent cumula-
tive binding and internalization. At 500 pM ET-1, 4.3
fmol of peptider106 cells were associated within 15
min; after this time the rate of association decreased.
Fig. 3. LECs lose endothelin receptors with time in culture.
 .Freshly adherent LECs filled squares or cells which had been
 .  .cultured for 24 h 378C open triangles or at 48C filled triangles
were subjected to a 24-hr48C binding protocol in the presence of
w125 x4–6 pM I ET-1 and different concentrations of unlabeled
ET-1. Assays were terminated and cell-associated radioactivity
determined as described in Section 2. Freshly adherent LECs
 .were also subjected to a 48-hr48C binding protocol open squares
to check that reactions were complete. Data are means"standard
deviations for duplicate or triplicate determinations in each of
four independent experiments.
Fig. 4. LECs lose endothelin receptor mRNA with time in
culture. Total RNA was obtained from freshly isolated cells,
freshly adherent cells cells cultured for 2–4 h to permit attach-
.ment and cells cultured for 24 h. Samples of total RNA were
separated on a formaldehyderagarose gel. Northern analysis was
 .performed as described in Section 2. A ET receptor mRNA;B
 .B 18S RNA.
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w125 xFig. 5. Total association of I ET-1 with LECs at 378C. LECs
w125 xwere exposed to 4–6 pM I ET-1 together with 50 or 500 pM
unlabeled ET-1 for the times shown. Surface binding was deter-
mined by acid washing as described in Section 2. Total associa-
 .tion ssurface boundqcell-internalized of ET-1 is shown. Val-
ues are mean"standard deviations for duplicate determinations
w125 xin each of three separate experiments. Squares, I ET-1 only;
triangles, plus 50 pM ET-1; circles, plus 500 pM ET-1.
This value was similar to that seen in the 24 hr48C
assay, suggesting that at 378C and 500 pM ET-1 most
of the cells’ receptors were occupied within 15 min
 .also see Fig. 8 . At 5 pM ET-1, association exhibited
a near-linear relationship with time correlation coef-
.ficients0.98 and at 1 h, the total association of
ET-1 was 0.3"0.03 fmolr106 cells.
The decrease in endothelin receptors with time in
 .culture see above leading to an equivalent decrease
in sequestration was confirmed using the 378Cr1 h
assay. Over 48 h the capacity of LECs to associate
w125 x with 5 pM I ET-1 diminished dramatically Fig.
.5 . Cells cultured for 24 h had a total capacity for
association of 1.4"0.4 fmoles of ET-1r106 cells
mean"S.D. for four independent experiments; see
. 6Fig. 6 inset considerably less than the 4.3 fmolr10
cells calculated from Fig. 5.
The endothelin receptor complex is known to be
w xlabile at low pH 32,33 . In cultured human vascular
smooth muscle cells acid washing has been used to
distinguish between surface-bound and internalized
w xligand 34 . In the present experiments, four acid
washes were necessary to liberate completely the
 .surface bound ligand data not shown . Repeated acid
washes were employed to assess the relative impor-
Fig. 6. LECs lose endothelin association capacity with time in
culture. LECs were cultured at 378C for different times prior to
 .  .association assay 378C, 1 h , without filled squares or with
 .open squares 10 mM cycloheximide. Inset: cells cultured for 24
 .h open squares had a total association capacity in the 378C, 1 h
6 assay of 1.43"0.40 fmol of peptider10 cells mean"standard
.deviation for four independent experiments . Freshly adherent
 .cells filled squares, data taken from Fig. 4 had a greater
association capacity.
w125 xFig. 7. LECs rapidly internalize bound I ET-1. LECs were
w125 xexposed to 4–6 pM I ET-1 together with 50 or 500 pM
unlabeled ET-1 for the times shown. Surface-bound and cell-in-
ternalized data from the experiment described in Fig. 4 were used
 .to calculate the ratio cell-internalized: surface bound . Squares,
w125 xI ET-1 only; triangles, plus 50 pM ET-1; circles, plus 500 pM
ET-1.
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 .tance of ET internalization at 378C Fig. 7 . Internal-
ization is expressed as a ratio in order to compare the
very different absolute values obtained at different
ET concentrations. The ratio internalized
.  .ligandrsurface ligand is high )1 even at early
time points, suggesting rapid internalization of the
complex. At 5 and 50 pM ET-1 the time-dependence
of internalization is very similar while at 500 pM,
apparently less ligand is internalized. This observa-
tion is consistent with a rapid occupation of the
surface receptors at 500 pM ET-1 which saturates the
internalization process.
3.4. ET-1-induced down-regulation of ET receptors:
cycloheximide sensiti˝ity
LECs were exposed to unlabeled ET-1 and then
washed extensively to remove unbound ligand before
using the 378C, 1 h association protocol. Within 1 h,
50 or 500 pM unlabeled ET-1 occupied 61 and 84%
 .respectively of the cells’ association capacity Fig. 8 .
In order to measure recovery following down-regu-
lation cells were treated with 500 pM unlabeled ET-1
for 1 h and the association capacity was measured
 .over longer time intervals Fig. 9 . As expected,
Fig. 8. Homologous downregulation of the ET receptor. LECsB
were exposed to 50 or 500 pM unlabeled ET-1 for the times
shown, then washed four times with buffer to remove unbound
ligand. Cells were then assayed for association capacity using
w125 x4–6 pM I ET-1 for 1 h at 378C. Data are mean"standard
deviations for duplicate determinations in three separate experi-
ments. Filled squares, control washed cells; open squares, cells
exposed to 50 pM unlabeled ET-1; open triangles, cells exposed
to 500 pM unlabeled ET-1.
Fig. 9. Recovery of ET receptors from homologous down-regu-B
lation. LECs were exposed to 500 pM unlabeled ET-1 for 1 h,
then washed four times with buffer to remove unbound ligand.
Cells were assayed for association capacity at different times
after washing. Data are mean"half-range for duplicate determi-
nations in two independent experiments: one in which cells were
freshly adherent, and one in which cells had been cultured for 24
h. Filled squares, down-regulated cells with no cycloheximide
present during the recovery period; open squares, 10 mM cyclo-
heximide present during the recovery period.
control cells which had been washed in the same way
exhibited a decline in association capacity after 24 h
in culture. In the first 3–4 h, when only a minor loss
of association was apparent in the control cells, bind-
ing capacity in the down-regulated cells was in-
creased from 15 to 25% of the control value. When
the same experiment was conducted in the presence
of 10 mM cycloheximide the recovery of binding
capacity over 24 h was attenuated. The exposure of
control cells to cycloheximide had essentially no
effect on binding 97"12% of the time-matched,
.cycloheximide untreated cells: see Fig. 6 but had
significantly more effect on down-regulated cells 61
"19% of the time-matched, cycloheximide untreated
.cells: Fig. 9 .
In order to examine the long-term effects of
down-regulation, LECs were treated with various
concentrations of ET-1 for 6 h, and then harvested for
 .analysis of ET receptor mRNA levels Fig. 10 .B
There was no apparent change in the receptor mRNA
levels after exposure to 50 or 500 pM ET-1, however
at 5 nM ET-1 there was a significant decrease in ETB
receptor mRNA levels to 50% of the control.
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Fig. 10. Effect of exogenous ET-1 on LEC receptor mRNA.
LECs were treated for 6 h with 50, 500 or 5000 pM ET-1. Total
 .RNA 10 mg from each sample was analyzed as described in
Section 2. Data are expressed as the ratio of the treated sample to
the control sample. Each point is the mean"SEM for determina-
tions from three independent experiments. ) P -0.03.
Fig. 11. Endothelin association and metabolism have similar
concentration dependencies. LECs were washed four times with
w125 xbuffer and then exposed to 4–6 pM I ET-1 with different
concentrations of unlabeled ET-1 for 24 h. At this time cells were
w125 xwashed and solubilized to measure the cell-associated I ET-1.
The cell medium was centrifuged to remove all non-adherent
cells, and the cell-free supernatant was made 10% wrv with
TCA and recentrifuged. Acid supernatants were counted to deter-
w125 xmine the amount of acid-soluble metabolites of I ET-1. Data
are mean"standard deviations for duplicate determinations in
 .two separate experiments. Filled squares left-hand scale , cell-
w125 x  .associated I ET-1; open squares right-hand scale , acid-solu-
w125 xble I . Inset: acid-solublertotal radioactivity at short incuba-
w125 xtion times; squares, I ET-1 only; triangles, plus 50 pM ET-1;
circles, plus 500 pM ET-1.
[125 ]3.5. Metabolism of I ET-1
Use of the 378Cr1 h association protocol assumes
w125 xthat metabolism of internalized I ET-1 was slow
enough to cause little loss of radioactivity from the
w xcells. We have reported previously 19 that the pre-
w125 xdominant cell-permeable radiometabolite of I ET-
w125 x1 is TCA soluble, while I ET-1 itself is TCA-pre-
cipitable; therefore metabolism can be defined as the
appearance of TCA-soluble radioactivity in the
medium. At 1–2 h the appearance of TCA-soluble
 .  .radiometabolite s is indeed minimal Fig. 11, inset .
Hence, the concentration dependencies of association
w125 xand metabolism of I ET-1 in a 24 h, 378C proto-
col were examined; it is apparent from Fig. 11 that
association and metabolism exhibited very similar
concentration dependencies.
4. Discussion
4.1. Measurement of ET binding
In most systems examined the reaction of ET with
its receptor is essentially irreversible. Binding of ET
to its receptor has an on-rate of 5=106 My1 sy1
w x y3 31,35 , and an off-rate of 2.4=10 rh s0.67=
y6 y1 w x. 10 s ; 32 yielding a calculated K off-d
.rateron-rate of 0.13 pM. The very low value for the
off-rate means that the equilibrium requirement for
generating a formal Scatchard plot cannot be met;
however Scatchard-format plots of irreversible bind-
ing data are approximately linear except at high
w x w xligand concentrations 31 . We 25,27 and others
w x26,36 have used Scatchard format plots to estimate
the apparent K and B of ET receptors ind max
hepatic-derived systems. In examining the association
w xof ET with Kupffer cells 27 we found that Scatchard
format plots of the data generated straight lines,
despite the irreversibility of ligand–receptor binding
and the use of whole cells at 378C.
In order to compare data obtained using Kupffer
cells with the present data, we constructed Scatchard
w125 xformat plots of I ET-1 association with LECs
using both the 378C, 1-h protocol and a 48C, 4-h
 .protocol data not shown which abrogates internal-
ization of radioligand. At 48C, the apparent K valued
 .for LECs 320 pM is very similar to that found in
 w x.Kupffer cells 270 pM: 27 . In Kupffer cells, we
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found apparent B values of 3000 receptorsrcell.max
In parallel experiments, the apparent B for LECsmax
was 6 fmol per million cells, or about 3600 recep-
torsrcell. At 378C, the apparent K values for Kupf-d
fer cells was 29 pM (10-fold difference from the
.value obtained at 48C and the apparent K value ford
LECs is shifted by a similar factor, to 36 pM. In both
cell types, experiments performed at 378C yielded
apparent B values which were only 40% of themax
values found at 48C. Extrapolations from Scatchard-
w xformat plots overestimate the value of B 31 ,max
hence the disparity between the Scatchard extrapola-
 .tion and the absolute values 2600 receptorsrcell
derived from Fig. 3.
4.2. Endothelin receptor type and number in li˝er
endothelial cells and other hepatic cells
The present study shows that liver endothelial
w xcells, like Kupffer cells 26,27 possess predomi-
nantly ET receptors. The other major hepatic cellB
types — Ito cells and hepatocytes — contain both
w xET and ET endothelin receptors 25,26 . ApparentA B
 .Scatchard-format B values for hepatocytes, LECsmax
and lipocytes Ito cells, fat-storing cells, hepatic stel-
.late cells have been reported previously as recep-
torsrmg DNA; on this basis lipocyte receptors ex-
ceed those of LECs 32-fold and of hepatocytes 84-fold
w x26 . Assuming equal amounts of DNArcell in each
cell type and using the Scatchard-format B valuesmax
noted above, lipocytes have 32 times 3600 recep-
 .torsrcell present data or 84 times 1200
w xreceptorsrcell 25 , i.e. between 114 000 and 101 000
receptorsrcell. These values are comparable with
w xthat of 116 000 receptorsrcell reported 37 for first-
passage human hepatic stellate cells.
The contribution of different cell types to the total
hepatic pool of ET receptors can be calculated: LECs,
KCs, Ito cells and hepatocytes represent respectively
18, 15, 8 and 58% of the cell numbers in rat liver
w x38 . Correcting the percentage of cell numbers by the
receptorsrcell for each cell type yields receptor con-
tributions of 6.5, 4.3, 82.5 and 6.7%, respectively.
4.3. Homologous down-regulation and reco˝ery of
ET receptors
The present study shows that in LECs ET is
rapidly internalized with concomitant disappearance
of free receptors, strongly suggesting that down-regu-
lation occurs by internalization of the receptor-ligand
w xcomplex. Chun and co-workers 39 reported that ETA
receptors are localized in plasma membrane caveolae,
and that receptor-ligand binding and consequent sig-
nal transduction occur in these membrane invagina-
tions. Whether ET receptors behave in a similarB
fashion remains to be determined. The slow recovery
of ET binding in down-regulated LECs suggests that
these cells are incapable of rapidly recovering their
ET responsiveness after treatment with high G1
.nM concentrations of the agonist. In aortic my-
ocytes, recovery of down-regulated ET receptors has
been reported not to be dependent on protein synthe-
w xsis 35 , suggesting a rapidly recycling ‘transport’
role for the receptor in these cells. However, the
present study shows that in common with Kupffer
w xcells 27 recovery of down-regulated ET receptors in
LECs is dependent upon protein synthesis.
The progressive loss of receptors with time in
culture might be due to secretion of autacoid ET with
concomitant receptor down-regulation, or it might be
that the culture conditions are insufficient to maintain
receptor numbers. To distinguish between these pos-
sibilities, we measured ET secretion from LECs using
radioimmunoassay; over a 24-h period, only 2–3 pg
 . 6of immunoreactive ET f1 fmol per 10 cells was
 .detected data not shown . Moreover, during incuba-
w125 xtion of endothelial cells with I ET-1 for 24 h at
 .378C Fig. 11 , there is a progressive decline in
w125 x cell-associated I ET-1 when 10–100 pM i.e. fmol
.in 1 ml exogenous unlabeled ET-1 is added; this
suggests that any effective endogenous contribution
is -10 fmol during this period.
[125 ]4.4. Metabolism of I ET-1
 .During long )4 h incubations at 378C, Kupffer
w125 xcells metabolize I ET-1 and release membrane
 . w xpermeable, TCA-soluble radiometabolite s 19 . A
concentration of unlabeled ET-1 high enough to satu-
rate receptor-dependent ligand internalization also at-
w125 xtenuates metabolism of I ET-1. This implies that
metabolism is intracellular and dependent upon the
saturable uptake mechanism. During a 24-h incuba-
w125 xtion with I ET-1 LECs retain much of the peptide
or its larger metabolites and the release of TCA-solu-
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ble radioactivity is rather slow. Relative to short-term
w125 xassays, the curve for cell-associated I ET-1 is
shifted to the right, indicating that the lower concen-
trations of peptide have been more completely re-
moved. The curve for the release of TCA-soluble
radioactivity parallels the association curve, consis-
tent with a mechanism in which metabolism is depen-
dent upon internalization via the ET receptor.
4.5. Failure of heterologous ligands to modulate ET
association
The presence of serum has no significant effect
 .either on the level of ET receptor mRNA Fig. 1 orB
w125 xon the association of I ET-1 with the cells in a 1-h
 .association assay data not shown . In contrast, the
presence of serum increased the level of mRNA for
 .ET-1 and the secretion of peptide data not shown .
Mediators which modulate ET secretion by endothe-
lial cells might alter the extent of ET binding, either
directly by modulation of ET receptor expression or
indirectly by causing a ligand-dependent down-regu-
lation of receptor numbers. Rieder and co-workers
w x16 reported that TGF-b increased ET secretion by
liver endothelial cells isolated from guinea-pig. Liver
endothelial cells isolated from the rat show a similar
response; treatment with 100 pM TGF-b for 6 h
elevated the level of ET-1 mRNA 2–3-fold Eakes
.and Olson, submitted for publication . However,
TGF-b did not effect the level of mRNA for the ETB
w125 xreceptor, nor did TGF-b alter the binding of I ET-
 .1 data not shown .
Exposure to other proinflammatory mediators
 .TNF-a , LPS, or PAF for 18 h caused no substantial
w125 xchange in I ET-1 binding to LECs. PAF was
tested because we have shown that in Kupffer cells,
ET exposure causes an increase in the synthesis of
w xPAF 40 and it seemed appropriate to ascertain
 .whether a paracrine PAF-dependent modulation of
ET receptors was apparent in LECs. These negative
data provide a baseline for experiments in which we
have examined the production of ET-1 by LECs
treated with these mediators. It seems that under
these conditions, the production of ET-1 peptide by
the LECs is unlikely to generate a concentration of
ET-1 sufficient to cause autologous receptor down-
regulation.
4.6. Signaling responses of hepatic cells to ET
Endothelin-1 stimulation causes accumulation of
soluble inositol phosphate isomers via activation of
. w xphospholipase C in Kupffer cells 41 , hepatocytes
w x w x25 , and Ito cells 42 . Moreover, ET-1-stimulated
Kupffer cells exhibit a concentration-dependent re-
lease of arachidonic acid via activation of phospholi-
w x.pase A ; 41 . Preliminary experiments determined2
that in LECs there is no detectable ET-dependent
activation of signaling phospholipases A and C.2
Moreover, ET-1 does not stimulate protein tyrosine
phosphorylation in LECs Eakes, Harvey and Olson,
.unpublished . The absence of detectable signal trans-
duction in LECs is not due to low surface receptor
density: Kupffer cells and LECs are comparable both
in size and receptorsrcell, while hepatocytes are
much larger and have fewer receptorsrcell; therefore
a much lower surface receptor density. It seems
possible that the LEC ET receptor is primarily a
clearance or scavenger receptor. It has been reported
that astrocytoma U373MG cells exhibit specific ET-1
binding, and that )80% of the ET bound is rapidly
internalized; however in these cells ET does not
stimulate Ca2q mobilization, phosphatidylinositol hy-
w xdrolysis or arachidonic acid release 43 .
4.7. Physiological significance of the endothelin re-
ceptor in the li˝er endothelial cell
The high effective density of ET receptors in the
vascular lumen and the irreversible binding of ET to
its receptor maintain ET in the circulation at low
w xlevels 44 . Using freshly adherent LECs in an associ-
ation assay, the mean ET receptor concentration typi-
cally is f10 pM. We found that in the presence of 5
nM ET-1, 60% of the ET receptors react within 1 min
 .and 80% within 5 min data not shown , which is
consistent with a rapid reaction of receptors at high
ligand concentrations. In small vessels, the effective
receptor concentration will be increased 103 fold
because of the relatively small volume of the lumen,
w xyielding an estimated 10 nM of ET receptors 44 .
Since the receptor ligand interaction is dominated by
 .the on-rate see above one can transpose the concen-
trations of receptors and ligand; thus 5 pM ET would
react with comparable rapidity. However, the slow
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recovery of ET binding after down-regulation sug-
gests that the rapid, high-affinity clearance of ET by
LECs is limited to less than 1 pmole of peptide. As
the high-affinity removal of circulating ET by its
receptors is saturated, the ability of hepatocytes to
hydrolyze extracellular ET by a low-affinity process
w x19 may become important.
w125 xThe hepatic uptake of I ET-1 in the intact rat
w xwas examined by Furuya et al. 45 , who injected
labeled peptide into the femoral vein. At 10 min after
injection the hepatic distribution of radioactivity into
LECs, KCs, Ito cells and hepatocytes was 18, 12, 35
and 35%, respectively. At 60 min after injection the
distribution of radioactivity into these cells was 6, 6,
60 and 28%, respectively. These values can be com-
pared with the calculated contributions of different
cell types to the total hepatic pool of ET receptors
 .see above which are 6.5, 4.3, 82.5 and 6.7%, re-
spectively for LECs, KCs, Ito cells and hepatocytes.
w125 xAt 10 min after injection of I ET-1, LECs and
KCs have sequestered percentages of radioactivity in
excess of their contribution to the receptor pool,
while at 60 min the sequestered radioactivity matches
their receptor contributions. In contrast, Ito cell se-
w125 xquestration of I ET-1 increases from 10 to 60 min,
but never rises to match the cells’ receptor comple-
ment. This suggests that in the intact rat, non-
parenchymal cells with a lumenal aspect i.e. LECs
.and KCs bind and sequester systemic ET more
rapidly than do Ito cells, despite the disproportion-
ately large number of receptors in Ito cells. This is
because Kupffer cells are abundant in the periportal
w xregion of the liver 46,47 and will respond first to
systemic ET entering the liver. Ito cells are located
w xpredominantly in the acinus 48 and are responsible
w xfor ET-driven redistribution of sinusoidal flow 49 .
The concentration of systemic ET detected by Ito
cells will be attenuated because of ET clearance by
w125 xKupffer cells and LECs; when I ET-1 is injected
into the mesenteric vein of the intact rat the magni-
tude of labeling in the sinusoids is periportal)
w xmidzonal)pericentral 50 .
Under physiological or near-physiological condi-
tions therefore, LECs will stabilize circulating ET at
low basal levels. However, pathological conditions
such as endotoxemia can cause a very different re-
sponse; in the intact rat, infusion of bacterial endo-
 .toxin LPS, lipopolysaccharide into the mesenteric
vein causes a 9-fold increase in hepatic mRNA for
ET-1 within 3 h. Under these conditions, the circulat-
ing levels of immunoreactive ET-1 also increase 8.5-
w xfold after 6 h 17 . LECs isolated from LPS-treated
animals show elevated mRNA for the ET receptorB
w xat 12 h post-treatment 17 and at 24 h post-treatment
ET binding is increased 2-fold Harvey, Miller and
.Olson, unpublished . These responses seem to occur
by a paracrine signaling mechanism: Kupffer cells
 .respond to bacterial endotoxin LPS by secreting
TGF-b while LECs respond to TGF-b but not to
. LPS with enhanced ET secretion Eakes and Olson,
.unpublished . Hepatic dysfunction caused by endo-
toxemia in the rat is attenuated by the blockade of
ET receptors but not by ET receptor antagonistsB A
w x51 , suggesting either a special vulnerability of cells
 .i.e. Kupffer, endothelial expressing exclusively ETB
receptors, andror that ET receptor-mediated path-B
ways have selective deleterious effects. The ability of
LECs to sequester systemic ET under normal and
.perhaps, mildly pathophysiological conditions is
markedly distinct from their ability to elevate sys-
temic ET under more extreme circumstances.
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